Supervised drug testing instructions (PDF, 221.89 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Tocilizumab, ROACTEMRA® – in treatment of rheumatic diseases (PDF, 210.29 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Tofacitinib, Xeljanz® – in treatment of rheumatic diseases (PDF, 209.85 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
TRH-test (Pt-TRH-R1, Pt-TRH-R2) (PDF, 115.08 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
urine albumin-creatinine ratio (PDF, 230.48 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Urine albumin-creatinine ratio (PDF, 119.24 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Urine sample for identification of Chlamydia and Gonorrhea (U-CtGcNhO, 4816) (PDF, 332.38 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Urine sampling of non-toilet trained child (PDF, 269.62 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Ustekinumab, STELARA ® – in treatment of rheumatic diseases (PDF, 208.18 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|